StockNews.AI
CDLX
StockNews.AI
204 days

Rosen Law Firm Urges Cardlytics, Inc. (NASDAQ: CDLX) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

1. Rosen Law Firm investigates allegations of misleading statements by Cardlytics. 2. Class action was filed for stockholders with losses over $100K. 3. Allegations claim Cardlytics failed to disclose risks affecting revenue growth. 4. Investors might recover damages if they participate in the lawsuit. 5. Shareholders must file lead plaintiff motions by March 25, 2025.

9m saved
Insight
Article

FAQ

Why Bearish?

Lawsuits often negatively impact stock prices; past examples include similar situations.

How important is it?

The lawsuit directly affects investor trust, which impacts CDLX's stock valuation.

Why Short Term?

The upcoming legal rulings may affect stock price quickly.

Related Companies

Rosen Law Firm Urges Cardlytics, Inc. (NASDAQ: CDLX) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--()--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Cardlytics, Inc. (NASDAQ: CDLX) between March 14, 2024 and August 7, 2024. Cardlytics describes itself as a company that “operates an advertising platform in the United States and the United Kingdom.”

For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.

The Allegations: Rosen Law Firm is Investigating the Allegations that Cardlytics, Inc. (NASDAQ: CDLX) Misled Investors Regarding its Business Operations.

According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) increasing consumer engagement led to an increase in consumer incentives; (2) Cardlytics could not increase its billings commensurate with the increased consumer engagement; (3) as a result, there was a significant risk that its revenue growth would slow or decline; (4) the changes to Cardlytics’ Ads Decision Engine (“ADE”), which led to increased consumer engagement, led to the “underdelivery” of budgets and customers billing estimates; and (5) as a result of the foregoing, defendants’ positive statements about Cardlytics’ business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

What Now: You may be eligible to participate in the class action against Cardlytics, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by March 25, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

Related News